,
, Writing -original draft: Anne-Caroline Jeannin
Marine Halbron, Christian Funck-Brentano, Agnès Hartemann, Olivier Bourron. case of Keutel syndrome, J Thromb Haemost, vol.9, issue.6, p.21435166, 2011. ,
Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma. BMC Cancer, vol.9, p.302, 2009. ,
Differential gene expression analysis of human entorhinal cortex support a possible role of some extracellular matrix proteins in the onset of Alzheimer disease, Neurosci Lett, vol.468, issue.3, pp.225-233, 2010. ,
Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor kappaB ligand, osteoprotegerin, and neuropathy, J Clin Endocrinol Metab, vol.99, issue.11, pp.4250-4258, 2014. ,
A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population, Diabetologia, vol.36, issue.2, pp.150-154, 1993. ,
The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort, Diabet Med, vol.19, issue.5, p.12027925, 2002. ,
Influence of height on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy. Diabetes Care, 1987. ,
, , vol.10, pp.613-619
A Role for Insulin in Diabetic Neuropathy, Front Neurosci, vol.10, p.581, 2016. ,
Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2, J Biol Chem, vol.277, issue.6, pp.4388-94, 2002. ,
Target-dependent inhibition of sympathetic neuron growth via modulation of a BMP signaling pathway, Dev Biol, vol.315, issue.2, pp.404-421, 2008. ,
Dendrite complexity of sympathetic neurons is controlled during postnatal development by BMP signaling, J Neurosci, vol.33, issue.38, pp.15132-15176, 2013. ,
Inhibition of glial maturation by bone morphogenetic protein 2 in a neural crest-derived cell line, Dev Neurosci, vol.27, issue.1, pp.37-48, 2005. ,
The role of bone morphogenetic protein-2 in vivo in regeneration of peripheral nerves, Br J Oral Maxillofac Surg, vol.45, issue.3, pp.197-202, 2007. ,
Extracellular matrix components in peripheral nerve regeneration, Int Rev Neurobiol, vol.108, p.24083438, 2013. ,
Matrix Gla protein C-terminal region binds to vitronectin. Co-localization suggests binding occurs during tissue development, Matrix Biol, vol.24, issue.5, pp.353-61, 2005. ,
Matrix gla protein binds to fibronectin and enhances cell attachment and spreading on fibronectin, Int J Cell Biol, p.807013, 2014. ,
Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost, vol.104, pp.811-833, 2010. ,
Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients. Diabetes Care, vol.36, p.23877986, 2013. ,
Maternal and fetal sequelae of anticoagulation during pregnancy, Am J Med, vol.68, issue.1, pp.90181-90184, 1980. ,
Vitamin K enhances the production of brain sulfatides during remyelination, PLoS One, vol.13, issue.8, p.203057, 2018. ,
Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability, Cell, vol.86, issue.2, pp.209-228, 1996. ,
Age-dependent survivalpromoting activity of vitamin K on cultured CNS neurons, Brain Res Dev Brain Res, vol.73, issue.1, pp.90041-90049, 1993. ,
Type 2 diabetes in France: epidemiology, trends of medical care ,
, Presse Med, vol.42, issue.5, pp.830-838, 2013.
Toll-like receptor 4 and tumor necrosis factor-alpha as diagnostic biomarkers for diabetic peripheral neuropathy, Neurosci Lett, vol.585, pp.28-32, 2015. ,
NSE, a potential biomarker, is closely connected to diabetic peripheral neuropathy. Diabetes Care, vol.36, pp.3405-3415, 2013. ,
Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review, Int J Mol Sci, vol.20, issue.3, 2019. ,
Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness, Am J Hypertens, vol.31, issue.9, pp.988-94, 2018. ,
Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease, Kidney Blood Press Res, vol.41, issue.3, pp.231-240, 2016. ,
Inactive matrix Gla protein is a novel circulating biomarker predicting retinal arteriolar narrowing in humans, Sci Rep, vol.8, issue.1, p.30305657, 2018. ,
Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane Database Syst Rev, vol.17, p.4572, 2007. ,
Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial, Clin Ther, vol.27, issue.8, pp.1164-80, 2005. ,
Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts, Arch Biochem Biophys, vol.419, issue.1, pp.31-40, 2003. ,
Efficacy of alpha-lipoic acid in diabetic neuropathy, Expert Opin Pharmacother, vol.15, issue.18, pp.2721-2752, 2014. ,
Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules, J Bone Miner Metab, vol.27, issue.1, pp.66-75, 2009. ,
Intake of dietary phylloquinone and menaquinones and risk of stroke, J Am Heart Assoc, vol.2, issue.6, p.455, 2013. ,
Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve, vol.11, pp.21-32, 1988. ,
Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care, vol.10, pp.432-472, 1987. ,
The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests, Neurology, vol.41, issue.6, pp.799-807, 1991. ,
The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity, Neurology, vol.42, issue.6, pp.1164-70, 1992. ,
Correlation between nerve conduction studies and clinical scores in diabetic neuropathy, Muscle Nerve, vol.24, issue.4, pp.555-563, 2001. ,
Endothelial Dysfunction as a Link Between Cardiovascular Risk Factors and Peripheral Neuropathy in Diabetes, J Clin Endocrinol Metab, vol.101, issue.9, p.27399351, 2016. ,
Muscle weakness: a progressive late complication in diabetic distal symmetric polyneuropathy, Diabetes, vol.55, issue.3, pp.5-1237, 2006. ,
Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes, J Diabetes Complications, vol.21, issue.1, pp.13-22, 2007. ,
Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry, Ann Neurol, vol.8, issue.6, pp.590-596, 1980. ,
Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy, Brain, vol.108, pp.861-80, 1985. ,
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study, Neurology, vol.43, issue.4, pp.817-841, 1993. ,